Our Portfolio

Rodin Therapeutics

Berkley Lynch, PhD | Massachusetts, United States

Project Overview

  • Biotechnology/For Profit Organization Type
  • $161,759 Funding Amount
  • 6/8/16 — 6/8/17 Project Duration
  • Drug Discovery Program
  • In Vivo Efficacy Therapeutic Stage
  • Closed Status

Rodin Therapeutics

Berkley Lynch, PhD | Massachusetts, United States

Selective HDAC2 Inhibitors for the Treatment of Cognitive Deficits in Alzheimer's Disease - Year 2, Part 2

GET IN TOUCH